260 related articles for article (PubMed ID: 18413137)
61. Establishment of the Ph. Eur. Hepatitis A virus RNA for NAT testing BRP batch 1.
Chudy M; Nübling CM; Blümel J; Daas A; Costanzo A
Pharmeur Bio Sci Notes; 2017; 2017():29-43. PubMed ID: 29017703
[TBL] [Abstract][Full Text] [Related]
62. Collaborative study for establishment of a global standard for the potency assay of human anti-D immunoglobulin.
Thorpe SJ; Sands D; Fox B; Schäffner G; Yu MW; Behr-Gross ME
Pharmeuropa Bio; 2004 Jan; 2003(2):9-26. PubMed ID: 14960260
[TBL] [Abstract][Full Text] [Related]
63. Collaborative study for the establishment of Ph. Eur. Biological Reference Preparation for Human tetanus immunoglobulin batch 2.
Stickings P; Tierney R; Hockley J; Rigsby P; Terao E
Pharmeur Bio Sci Notes; 2024; 2024():1-11. PubMed ID: 38252512
[TBL] [Abstract][Full Text] [Related]
64. Collaborative study for the calibration of a replacement international standard for diphtheria toxoid adsorbed.
Stickings P; Rigsby P; Coombes L; Malik K; Matejtschuk P; Sesardic D
Biologicals; 2010 Sep; 38(5):529-38. PubMed ID: 20646934
[TBL] [Abstract][Full Text] [Related]
65. Establishment of detection antibodies BRRs batch 5 for in vitro potency assay of hepatitis A vaccines by ELISA.
Morgeaux S; Koy A; Manniam I; Regourd E; Variot P; Milne C
Pharmeur Bio Sci Notes; 2019; 2019():1-10. PubMed ID: 30648966
[TBL] [Abstract][Full Text] [Related]
66. Establishment of Ph. Eur. Hepatitis C Virus RNA for NAT testing BRP batch 2.
Pisani G; Le Tallec D; Costanzo A
Pharmeur Bio Sci Notes; 2023; 2023():15-41. PubMed ID: 37347249
[TBL] [Abstract][Full Text] [Related]
67. Collaborative study for the establishment of a candidate equine influenza subtype 2 American-like strain A/EQ/South Africa/4/03 - horse antiserum biological reference preparation.
Daly J; Daas A; Behr-Gross ME
Pharmeuropa Bio; 2007 Dec; 2007(1):7-14. PubMed ID: 18413133
[TBL] [Abstract][Full Text] [Related]
68. Collaborative study for the establishment of replacement batches for somatropin CRS batch 1.
Daas A; Rafferty B; Behr-Gross ME
Pharmeuropa Bio; 2006 Nov; 2006(1):23-36. PubMed ID: 17270129
[TBL] [Abstract][Full Text] [Related]
69. Collaborative study for the establishment of the second international standard for vancomycin.
Rautmann G; Daas A; Buchheit KH
Pharmeur Bio Sci Notes; 2011 Nov; 2011(2):1-15. PubMed ID: 22225764
[TBL] [Abstract][Full Text] [Related]
70. Calibration of the WHO 5th IS for Blood Coagulation Factor IX, Concentrate and Ph. Eur. Human Coagulation Factor IX Concentrate Biological Reference Preparation Batch 3 and investigation of the suitability of an IS as potency standard for purified full-length recombinant FIX.
Gray E; Hogwood J; Dougall T; Rigsby P; Matejtschuk P; Terao E
Pharmeur Bio Sci Notes; 2021; 2021():26-68. PubMed ID: 33783349
[TBL] [Abstract][Full Text] [Related]
71. An international collaborative study to replace the 1st international standard for prekallikrein activator.
Longstaff C; Behr-Gross ME; Daas A; Lackner F
Vox Sang; 2005 Feb; 88(2):143-51. PubMed ID: 15720613
[TBL] [Abstract][Full Text] [Related]
72. Collaborative study for establishment of the European Pharmacopoeia BRP batch 1 for diphtheria toxin.
Sesardic D; Prior C; Daas A; Buchheit KH;
Pharmeuropa Bio; 2003 Jul; 2003(1):5-21. PubMed ID: 14563306
[TBL] [Abstract][Full Text] [Related]
73. Collaborative study for the establishment of Human immunoglobulin for anticomplementary activity BRP replacement batches 3, 4, 5 and 6.
Miller L; Waibler Z; Regourd E; Jouette S
Pharmeur Bio Sci Notes; 2022; 2022():10-21. PubMed ID: 35384837
[TBL] [Abstract][Full Text] [Related]
74. Collaborative study for the establishment of erysipelas ELISA coating antigen. European Biological Reference Preparation batch no. 1.
Cussler K; Rosskopf-Streicher U; Volkers P; Milne C
Pharmeuropa Spec Issue Biol; 2001 Aug; 2001(1):75-88. PubMed ID: 11705102
[TBL] [Abstract][Full Text] [Related]
75. Collaborative study for the establishment of Ph. Eur. Human immunoglobulin for electrophoresis BRP batch 4.
Behr-Gross ME; Regourd E; Holtkamp W
Pharmeur Bio Sci Notes; 2022; 2022():37-54. PubMed ID: 35791813
[TBL] [Abstract][Full Text] [Related]
76. Collaborative study for the establishment of a European Phamacopoeia Biological reference preparation for Bordetella pertussis mouse antiserum for serological potency testing of acellular pertussis vaccines.
Poirier B; Bornstein N; Andre M; Marmonier D; Pares M; Vanhooren G; Rautmann G; Behr-Gross ME; Dobbelaer R; Fuchs F
Biologicals; 2003 Mar; 31(1):25-38. PubMed ID: 12623057
[TBL] [Abstract][Full Text] [Related]
77. International collaborative study to establish immunoglobulin (anti-D test) BRP batch 1.
Thorpe SJ; Fox B; Heath A; Behr-Gross ME; Virata ML; Yu MW
Pharmeuropa Bio; 2006 Nov; 2006(1):49-56. PubMed ID: 17270131
[TBL] [Abstract][Full Text] [Related]
78. A collaborative study to establish the 7th International Standard for Factor VIII Concentrate.
Raut S; Bevan S; Hubbard AR; Sands D; Barrowcliffe TW
J Thromb Haemost; 2005 Jan; 3(1):119-26. PubMed ID: 15634275
[TBL] [Abstract][Full Text] [Related]
79. Establishment of new and replacement World Health Organization International Biological Standards for human interferon alpha and omega.
Meager A; Gaines Das R; Zoon K; Mire-Sluis A
J Immunol Methods; 2001 Nov; 257(1-2):17-33. PubMed ID: 11687235
[TBL] [Abstract][Full Text] [Related]
80. Establishment of an erythropoietin CRS with stable measurable dimer content for SEC system suitability qualification.
Matejtschuk P; Duru C; Bristow AF; Burns CJ; Cowper B; Daas A; Costanzo A
Pharmeur Bio Sci Notes; 2019; 2019():11-26. PubMed ID: 30714898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
